Orion Group Holdings Inc ORN were climbing in early trading on Thursday, with optimism ahead of its fourth-quarter results.The company is a "unique beneficiary of marine infrastructure development, including enhancements to military assets, ports, maintenance, coastal protection and private deployment," according to DA Davidson.The Orion Group Holdings Analyst: Analyst Brent Thielman initiated coverage of Orion Group Holdings with a Buy rating and a price target of $11.The Orion Group Holdings Thesis: After ...

HEALWELL AI Receives Written Shareholder Approval for Pending Acquisition of Orion Health and Related FinancingJanuary 14, 2025 3:15 AM EST | Source: HEALWELL AIThe Company has obtained shareholder approval for its proposed acquisition of Orion Health and its previously announced $55 million bought-deal financing. The Company also announced that a Schedule A Bank has obtained internal risk approval for a senior secured credit facility in the amount of $50 million, subject to the Company finali ...

ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE13 JANUARY 2025 at 9.50 EET                   79,345 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 79,345 A shares have been converted into 79,345 B shares. The conversion has been entered into the Trade Register on 13 January 2025. The total number of shares in Orion Corporation is 141,134,278 which, after the conv ...

Collaboration and Regulatory Submission - Orion's collaboration partner Bayer has submitted an application to China's NMPA for the use of darolutamide in combination with ADT for metastatic hormone-sensitive prostate cancer (mHSPC) [1] - The submission is based on positive Phase III ARANOTE trial results showing a 46% reduction in the risk of radiological progression or death compared to placebo plus ADT in mHSPC patients [1] Market Approvals and Global Presence - Darolutamide, marketed as Nubeqa®, is already approved for mHSPC in combination with ADT and docetaxel in over 80 markets, including China [2] - The compound is also approved for non-metastatic castration-resistant prostate cancer (nmCRPC) in over 85 countries, including China [2] Company Overview - Orion is a globally operating Finnish pharmaceutical company with a focus on oncology and pain [3] - The company develops, manufactures, and markets human and veterinary pharmaceuticals, with a portfolio including proprietary and generic medicines and consumer health products [3] - Orion's net sales in 2023 amounted to EUR 1,190 million, with approximately 3,600 employees at the end of the year [3]

In our modern times of instant access to information through the Internet or two-day delivery with Amazon Prime, it can be hard to remember when it took a long timeHigh Dividend Opportunities, #1 On Seeking AlphaHDO is the largest and most exciting community of income investors and retirees with over +8000 members. We are looking for more members to join our lively group! Our Income Method generates strong returns, regardless of market volatility, making retirement investing less stressful, simple and strai ...

MANITOWOC, Wis., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations, and maintenance service solutions, announced today its selection for a three-year contract by a longstanding, nationwide Energy Service Company (ESCO) partner. This new contract and expanded relationship will commence in January 2025 and is anticipated to generate $5 - $10 million per year. Orion has been named on ...

SAN FRANCISCO and MANITOWOC, Wis., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging station, and maintenance service solutions, will present at Singular Research’s Best of the Uncovereds Conference and Webinar on Thursday, December 12th at 8:30 am PT at AMA’s Conference Center at the San Francisco Marriott Marquis. Registration for the webinar is free and open to all investors. CEO Mike J ...

Orion Energy Systems, Inc. (OESX) has secured a new contract to provide lighting retrofit solutions for a major building products distributor in North America. The distributor operates more than 400 locations across the region.The project will start in Orion’s third-quarter fiscal 2025 and is expected to continue for several years. The company estimates the total value of the contract to be between $12 million and $18 million, with about $1 million expected in fiscal 2025.Orion to Oversee Nationwide LED Lig ...

VANCOUVER, British Columbia, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (“Euro Manganese” or the "Company") announced today that it has amended the US$100 million funding package (the “Funding Package”) with OMRF (BK) LLC ("Orion"), which is managed by the Orion Resource Partners. The Funding Package, originally announced on November 28, 2023, supports the development of the Chvaletice Manganese Project (the "Project") in the Czech Republic, and ...

MANITOWOC, Wis., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations, and maintenance service solutions, announced today it has been selected to provide lighting retrofit solutions for a North American Building Products distributor covering over 400 locations. The project will commence in Orion’s Q3 FY25 and is anticipated to continue for several years. Orion values the total opport ...